Liquid Statin FloLipid Faces Possible FDA Withdrawal Over Missed Reports, Leaving Patients Who Can't Swallow Pills Weighing Options
The FDA proposed withdrawing FloLipid's approval after Salerno Pharmaceuticals missed required annual reports. Patients who cannot swallow pills should seek guidance before switching treatments.
Medical Daily ·